Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter Google Plus

Management of Type 2 Diabetes: New and Future Developments in Treatment

diabetes-cme

Management of Type 2 Diabetes: New and Future Developments in Treatment

Free CME

Click Here to Download Activity PDF

Source: Management of type 2 diabetes: new and future developments in treatment. Lancet. 2011;378:182–97.

Estimated Time to Complete Activity
.25 hours per video activity/.5 hours for initiative series

Publication Date
January 20, 2012

Publication Date
January 20, 2012

Faculty for Program
Emilia Pauline Liao, MD
Assistant Professor, Department of Medicine (Endocrinology)
Albert Einstein College of Medicine
New York, NY

Who Should Participate/Target Audience
This activity is designed for internists, primary care physicians, endocrinologists, and other healthcare professionals who treat and manage type 2 diabetes mellitus.

Overview of Methods and Participation
This two-video program is designed to improve the management and treatment of type 2 diabetes mellitus in the general population. There are no fees for participating and receiving CME credit for this activity.

Credit Designation
Each of the two videos is eligible for one-quarter (0.25) CME credit.  To receive up to half (.5) CME credits, you must: a) view each of the videos b) review the associated journal article c) complete each test associated with the video d) achieve a score of 70% or higher on the test and e) complete an evaluation form. You will then be able to print out your CME certificate.

Technical Requirements

  • A broadband internet connection
  • Operating system: Microsoft Windows 98 or later; Mac OS X
  • Web browser: Microsoft Internet Explorer 6.0 or later; Mozilla Firefox 1.5 or later; Apple Safari
  • Adobe Flash Player 9.0 or later (Available at: get.adobe.com/flashplayer/)

Learning Objectives
At the conclusion of the entire initiative, two videos in total, participants should be able to:

  1. Explain the effects of type 2 diabetes mellitus on both the individual and society.
  2. Apply up-to-date, evidence-based, validated guidelines to the treatment of patients with type 2 diabetes mellitus, including novel treatments.
  3. Manage complex pharmacologic treatment including promising new agents as well as older, well-understood pharmacotherapies.

Disclosures
Faculty
Dr. Liao has a single disclosure for educational material sponsored by Merck.

Temple
The planning staff of Temple has nothing to disclose.

Elsevier
The planning staff of Elsevier has nothing to disclose.

BetterCME
The medical director and the production staff at BetterCME have nothing to disclose.

Supported by an educational grant from Lilly USA, LLC.

Designation and Accreditation Statement
Temple University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) and designates this enduring educational activity for a maximum of .5 AMA PRA Category 1 Credits™.   Physicians should only claim credit commensurate with the extent of their participation in the activity.

Disclaimer—Patient Management
This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Disclaimer—Temple and Elsevier
The material presented in these videos for continuing education activity does not necessarily reflect the views and opinions of Temple or Elsevier.  In addition, the faculty does not endorse or recommend any techniques, commercial products, or manufacturers.  The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the U.S. Food and Drug Administration (FDA).  All viewers and continuing education participants should verify all information before treating patients or utilizing any product.

Unlabeled and Investigational Usage(s)
The audience is advised that this continuing educational activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States.  The faculty members have been made aware of their obligation to disclose such usage.

Copyright Statement
Elsevier© and Temple.  All journal documents accessed from this page are viewed as a resource of Elsevier© and this CME program is considered part of Temple programming with BetterCME and The Doctor’s Channel, all rights reserved.